Market Overview:
The global AICAR market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for AICAR in research and biopharmaceutical applications, and increasing investments by key players in R&D activities. However, stringent regulatory norms may restrain the growth of the global AICAR market during the forecast period. Based on type, the global AICAR market is segmented into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. The min purity less than 98% segment is expected to account for a major share of the global AICAR market during the forecast period. This can be attributed to high demand for low-purity products from research institutes and biopharmaceutical companies.
Product Definition:
AICAR is a molecule that activates the enzyme AMPK (AMP-activated protein kinase), which in turn, promotes the use of glucose and fatty acids for energy production in cells. In addition to its effects on AMPK, AICAR has also been shown to improve muscle function and protect heart tissue from damage.
Min Purity Less Than 98%:
The global market for Min Purity Less than 98%, also known as AICAR, is expected to witness significant growth over the forecast period. The growth of the market can be attributed to increasing research and development activities in the field of biotechnology. Increasing investments in R&D by companies and universities are anticipated to drive demand for high-purity amino acids from 2018 to 2025.
Min Purity 98%-99%:
Min Purity 98%-99% is a special type of AICAR developed by the researchers for use in food and beverage applications. It has been demonstrated to have better stability than conventional AICAR products under various storage conditions including room temperature, refrigeration, and frozen.
Application Insights:
The global aicar market is segmented by application into research and biopharmaceutical. The research application segment dominated the overall industry in terms of revenue in 2017, owing to extensive R&D activities for the development of novel applications for aicar. For instance, researchers at Loma Linda University developed an innovative way to deliver drugs through bacterial cell walls that could revolutionize drug delivery systems.
AICAR has been studied extensively as a potential sports supplement ingredient due to its ability to promote lean body mass growth and improve performance during training when supplemented at high doses (5-6 g/day). However, there are no regulations or standards set for labeling nutritional supplements containing this compound which has led some health authorities worldwide including FDA in the U.S.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high research and development activities by major companies. In addition, increasing focus on drug discovery programs by pharmaceutical companies in this region is anticipated to propel product demand.
Asia Pacific AICAR market is expected to grow at a lucrative rate over the forecast period due to factors such as growing biopharmaceutical industry and rising R&D expenditure by governments of various countries including China, India, Singapore and Japan among others are anticipated drive growth in this region. Moreover, increasing number of clinical trials for new drugs being conducted in Asia Pacific countries will further boost regional growth during the forecast period (2018-2030).
Europe also accounted for a significant share of revenue generated from AICAR globally due with presence of key manufacturers such as Cargill Inc., Roquette (Sodexo) Ltd.
Growth Factors:
- Increasing awareness about the benefits of AICAR among athletes and bodybuilders.
- Rising demand for AICAR as a performance-enhancing drug among professional athletes.
- Growing popularity of AICAR as a weight loss supplement among obese and overweight people.
- Increasing research on the potential health benefits of AICAR in treating various diseases and conditions.
- Growing number of online retailers selling AICAR supplements, making it easily accessible to consumers worldwide
Scope Of The Report
Report Attributes
Report Details
Report Title
AICAR Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Biopharmaceutical
By Companies
Abcam, Merck, Cayman Chemical, Bio-Techne, AG Scientific, Beyotime, ApexBio Technology, Enzo Biochem, STEMCELL Technologies, BPS Bioscience, PeproTech, Selleck Chemicals, Santa Cruz Biotechnology, BioVision, Hello Bio, Focus Biomolecules, AG Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global AICAR Market Report Segments:
The global AICAR market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Biopharmaceutical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- Merck
- Cayman Chemical
- Bio-Techne
- AG Scientific
- Beyotime
- ApexBio Technology
- Enzo Biochem
- STEMCELL Technologies
- BPS Bioscience
- PeproTech
- Selleck Chemicals
- Santa Cruz Biotechnology
- BioVision
- Hello Bio
- Focus Biomolecules
- AG Scientific
Highlights of The AICAR Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Biopharmaceutical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the AICAR Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
AICAR is an acronym for "acetyl-L-carnitine." It is a nutritional supplement that has been shown to improve exercise performance.
Some of the major players in the aicar market are Abcam, Merck, Cayman Chemical, Bio-Techne, AG Scientific, Beyotime, ApexBio Technology, Enzo Biochem, STEMCELL Technologies, BPS Bioscience, PeproTech, Selleck Chemicals, Santa Cruz Biotechnology, BioVision, Hello Bio, Focus Biomolecules, AG Scientific.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 AICAR Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 AICAR Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 AICAR Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the AICAR Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global AICAR Market Size & Forecast, 2020-2028 4.5.1 AICAR Market Size and Y-o-Y Growth 4.5.2 AICAR Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Biopharmaceutical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global AICAR Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 AICAR Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Biopharmaceutical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Biopharmaceutical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Biopharmaceutical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Biopharmaceutical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Biopharmaceutical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 AICAR Market: Competitive Dashboard
14.2 Global AICAR Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam
14.3.2 Merck
14.3.3 Cayman Chemical
14.3.4 Bio-Techne
14.3.5 AG Scientific
14.3.6 Beyotime
14.3.7 ApexBio Technology
14.3.8 Enzo Biochem
14.3.9 STEMCELL Technologies
14.3.10 BPS Bioscience
14.3.11 PeproTech
14.3.12 Selleck Chemicals
14.3.13 Santa Cruz Biotechnology
14.3.14 BioVision
14.3.15 Hello Bio
14.3.16 Focus Biomolecules
14.3.17 AG Scientific